Analyst Jeff Johnson of Robert W. Baird maintained a Buy rating on Alcon (ALC – Research Report), retaining the price target of $110.00.

The company develops, manufactures, distributes, and sells technologies and devices for cataract, retinal, refractive surgery, as well as contact lenses and lens care products. Read More on ALC: Alcon ...

"We are making history with the bold innovation of PRECISION7," said Max Wolf, General Manager, Head of Vision Care and Contact Lenses at Alcon. "Now, patients can start and end every week fresh ...

Alcon expects 2024 sales of $9.8 billion to $9.9 billion, compared with prior guidance of $9.9 billion to $10.1 billion. It expects core earnings per share of $3 to $3.05, compared with a previous ...

Some key players in the Disposable Contact Lenses Market are The Cooper Companies, Inc., Novartis International AG, Johnson & ...

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the U.S. launch of PRECISION7®, the only one-week replacement contact lens with ...

"We are making history with the bold innovation of PRECISION7," said Max Wolf, General Manager, Head of Vision Care and Contact Lenses at Alcon. "Now, patients can start and end every week fresh with ...